Navigation Links
Dysfunctional chemokine receptor promotes candidiasis
Date:11/1/2013

Candida albicans is one of the leading causes of hospital-acquired infections in immune compromised patients. The risk of both developing candidiasis and the clinical outcome of infection is variable among patients, and the host-dependent factors that contribute to patient susceptibility to C. albicans infection are poorly understood. In this issue of the Journal of Clinical Investigation, Michail Lionakis and colleagues at the National Institute of Allergy and Infectious Diseases demonstrated that the chemokine receptor CX3CR1 is required for the interaction of C. albicans and macrophages in the kidney. Mice lacking this receptor were prone to C. albicans-induced kidney failure; however, these mice did not have increased fungal burden in other organs. Furthermore, the authors found that patients with a mutation in the gene encoding CX3CR1 were at higher risk of candidiasis. This study identifies an important role for the interaction of C. albicans and macrophages in disease progression and outcome.


'/>"/>

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related biology news :

1. Has modern science become dysfunctional?
2. Measuring progesterone receptor expression to improve hormone-receptor-positive cancer management
3. G protein-coupled receptor mediates the action of castor oil
4. BUSM study identifies receptors role in regulating obesity, type 2 diabetes
5. Cell receptor has proclivity for T helper 9 cells, airway inflammation
6. Steroid hormone receptor prefers working alone to shut off immune system genes
7. Jackson Laboratory researchers provide definitive proof for receptors role in synapse development
8. Dopamine-receptor gene variant linked to human longevity
9. How the tilt of a cell-surface receptor prevents cancer
10. Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury
11. Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2019)... ... January 16, 2019 , ... As the leader in ... the introduction of its own liver 3D cell culture models. In an effort to ... protocols and validation criteria so that any researcher can replicate these models for their ...
(Date:1/20/2019)... ... January 18, 2019 , ... Boston-based Laboratory as a Service (LaaS) ... effort to better express its continued expansion and service offerings for biotech and life ... kind of lab: one that is more agile and adaptable than ever before. One ...
(Date:1/10/2019)... ... January 10, 2019 , ... When Dr. James L. Sherley, M.D., Ph.D., ... to contribute a chapter to the new book Perinatal Stem Cells: Research and Therapy, ... to address a debilitating secret of stem cell medicine. For more than a ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... (PRWEB) , ... January 30, 2019 , ... ... section of the international tasting 5StarWines to promote and give recognition to producers ... The Wine Without Walls selection takes place in Verona, Italy, contemporaneously to the ...
(Date:1/24/2019)... , ... January 22, 2019 , ... Controlled Contamination Services ... teams in the US. Each of these valuable new team members will support its ... delivery model moving forward as CCS scales its business. This addition will enable CCS ...
(Date:1/24/2019)... ... January 22, 2019 , ... Outsourcing ... its own set of assumptions, and RFP creation and management generally requires manual ... like comparing apples to oranges. These challenges can ultimately lead to study start ...
(Date:1/21/2019)... ... 21, 2019 , ... Microbial Discovery Group (MDG), a leading ... institutional cleaning market. MDG’s SporActiv liquid and powder product line contains safe ingredients ... control, floor and tile cleaners, carpets, drains, portable restroom cleaning and more. ...
Breaking Biology Technology: